The etiology of insulin dependent diabetes mellitus in humans seems to entail an interaction between a susceptible genotype and an environmental stress. The recessive mutation diabetes in the mouse is consequently of interest as a model system for understanding such interactions. The diabetes gene itself does not determine whether a mild or a several diabetes syndrome will result; rather, its expression creates a diabetogenic environment that demands an increased insulin supply. The response to this stress is determined by other genetic factors in the inbred strain background. Thus, diabetes gene expression in certain inbred strains (C57BL/KsJ, CBA/J) is characterized by an abortive attempt to increase insulin supply, with insulinopenia, beta cell necrosis, and severe diabetes resulting. On the contrary, in other inbred strains (C57BL/6J, 129/J), the diabetogenic stress is met by an enhanced insulin secretion that is sustained indefinitely. An understanding of the action of modifing genes that change the course of murine diabetes from a severe juvenile-onset type to a mild maturity-onset type would be an important contribution to the understanding of diabetes in man. The objectives of the current research are to elucidate the site and mechanism of action of the db gene, and to understand how heredity and environment can interact in the diabetes-susceptible inbred mouse strains to produce beta cell necrosis. Feeding mutant mice a high protein-no carbohydrate diet allows full expression of the db gene while at the same time prevents beta cell necrosis and diabetes development in the suscetible C57BL/KsJ strain. We shall screen monolayer cultures of pancreatic islet cells from normal and mutant mice to test for expression of intrinsic genetic defect. We will use in vivo and in vitro tests to show how dietary carbohydrate might interact with C57BL/KsJ and CBA/J diabetes-susceptible genomes to culminate in beta cell necrosis and severe diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis, Diabetes, Digestive and Kidney Diseases (NIADDK)
Type
Research Project (R01)
Project #
5R01AM017631-11
Application #
3151080
Study Section
Mammalian Genetics Study Section (MGN)
Project Start
1977-06-01
Project End
1988-01-31
Budget Start
1985-02-01
Budget End
1986-01-31
Support Year
11
Fiscal Year
1985
Total Cost
Indirect Cost
Name
Jackson Laboratory
Department
Type
DUNS #
042140483
City
Bar Harbor
State
ME
Country
United States
Zip Code
Leiter, E H; Le, P H; Coleman, D L (1987) Susceptibility to db gene and streptozotocin-induced diabetes in C57BL mice: control by gender-associated, MHC-unlinked traits. Immunogenetics 26:6-13
Leiter, E H (1987) Analysis of differential survival of syngeneic islets transplanted into hyperglycemic C57BL/6J versus C57BL/KsJ mice. Transplantation 44:401-6
Leiter, E H; Prochazka, M; Shultz, L D (1987) Effect of immunodeficiency on diabetogenesis in genetically diabetic (db/db) mice. J Immunol 138:3224-9
Leiter, E H; Beamer, W G; Shultz, L D et al. (1987) Mouse models of genetic diseases. Birth Defects Orig Artic Ser 23:221-57
Leiter, E H; Fewell, J W; Kuff, E L (1986) Glucose induces intracisternal type A retroviral gene transcription and translation in pancreatic beta cells. J Exp Med 163:87-100
Prochazka, M; Premdas, F H; Leiter, E H et al. (1986) Estrone treatment dissociates primary versus secondary consequences of ""diabetes"" (db) gene expression in mice. Diabetes 35:725-8
Le, P H; Leiter, E H; Leyendecker, J R (1985) Genetic control of susceptibility to streptozotocin diabetes in inbred mice: effect of testosterone and H-2 haplotype. Endocrinology 116:2450-5
Roderick, T H; Langley, S H; Leiter, E H (1985) Some unusual genetic characteristics of BALB/c and evidence for genetic variation among BALB/c substrains. Curr Top Microbiol Immunol 122:9-18
Leiter, E H (1985) Type C retrovirus production by pancreatic beta cells. Association with accelerated pathogenesis in C3H-db/db (""Diabetes"") mice. Am J Pathol 119:22-32
Leiter, E H (1985) Differential susceptibility of BALB/c sublines to diabetes induction by multi-dose streptozotocin treatment. Curr Top Microbiol Immunol 122:78-85